Noevir Holdings Co., Ltd.: Business Overview, Financials & Competitive Analysis
Noevir Holdings Co., Ltd. scores 6/10 on the AskCyborg Cyborg Score (Solid). Established Japanese beauty and wellness conglomerate with diversified portfolio, strong dividend yield, and Asian market exposure, though facing valuation and growth headwinds in mature markets. Noevir demonstrates stable fundamentals with diversified revenue streams across cosmetics, pharmaceuticals, and health foods, plus an attractive dividend yield. However, recent stock performance.
What is Noevir Holdings Co., Ltd.'s industry? Noevir Holdings Co., Ltd. (noevirholdings.co.jp) operates in Cosmetics, Pharmaceuticals & Health Foods. AskCyborg classifies Noevir Holdings Co., Ltd. under Cosmetics, Pharmaceuticals & Health Foods in its company registry.
Noevir Holdings develops, produces, and sells cosmetics, toiletries, medical supplies, and food products across Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The cos...
Cyborg Score thesis
Established Japanese beauty and wellness conglomerate with diversified portfolio, strong dividend yield, and Asian market...
Read the full analyst-debate transcript →Get the Latest Noevir Holdings Co., Ltd. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeNoevir Holdings Co., Ltd. Overview
Pro stress-test →Noevir Holdings develops, produces, and sells cosmetics, toiletries, medical supplies, and food products across Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The cosmetics and pharmaceuticals & health food businesses jointly contribute the majority of the company's revenue, with a diversified portfolio spanning skincare brands like Noevir and NOV, health supplements, OTC pharmaceuticals, and functional drinks.
Strategic Profile
Pro stress-test →Noevir's strategy is rooted in meticulous product formulation using natural ingredients and advanced research techniques, crafting skincare and personal care products designed for discerning customers. The company has a presence in multiple countries worldwide and focuses on developing Asian markets, with approximately 60% domestic sales and 40% international revenue, balancing growth across regions.
Competitive Landscape
Pro stress-test →Noevir competes in the highly fragmented global cosmetics and beauty care industry against major players including Shiseido (Japan), SK-II (Procter & Gamble), and international brands like L'Oréal, Estée Lauder, and Korean beauty leaders. The company differentiates through heritage, natural ingredient focus, and direct-to-consumer beauty studio model, maintaining particular strength in Asian markets where it operates as a mid-tier premium player.
Industry Context
Noevir Holdings Co., Ltd. operates in Cosmetics, Pharmaceuticals & Health Foods.
Key facts
Founded: 1964 · Headquarters: Kobe, Japan · Employees: 1,500 · Revenue: ¥24.2B (FY2023) · Market cap: ¥157.8B (~$1.2B USD)